For instance, an injectable cryogel composed of gelatin and heparin facilitated effective angiogenic responses when used as a carrier for vascular endothelial growth factor (VEGF) and fibroblasts in the treatment of hindlimb ischemic disease [67]. This evidence concerns the gene VEGFA and ischemic disease.